Integral Derivatives’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$257K Sell
3,200
-24,100
-88% -$1.99M 0.01% 546
2017
Q4
$2.2M Buy
27,300
+13,800
+102% +$1.11M 0.04% 268
2017
Q3
$1.05M Sell
13,500
-3,200
-19% -$266K 0.02% 481
2017
Q2
$1.48M Buy
16,700
+3,800
+29% +$320K 0.03% 378
2017
Q1
$1.04M Buy
12,900
+5,600
+77% +$437K 0.02% 512
2016
Q4
$520K Buy
7,300
+1,300
+22% +$102K 0.01% 713
2016
Q3
$518K Sell
6,000
-8,400
-58% -$732K 0.01% 622
2016
Q2
$1.25M Buy
14,400
+1,700
+13% +$137K 0.03% 352
2016
Q1
$952K Sell
12,700
-1,600
-11% -$121K 0.03% 382
2015
Q4
$1.1M Buy
14,300
+4,500
+46% +$339K 0.03% 430
2015
Q3
$656K Sell
9,800
-6,200
-39% -$457K 0.02% 635
2015
Q2
$1.19M Sell
16,000
-17,600
-52% -$1.34M 0.03% 466
2015
Q1
$2.62M Buy
+33,600
New +$2.55M 0.06% 223
2014
Q3
Sell
-23,200
Closed -$1.48M 1487
2014
Q2
$1.48M Buy
+23,200
New +$1.41M 0.03% 534
2014
Q1
Sell
-25,900
Closed -$1.49M 1489
2013
Q4
$1.49M Buy
+25,900
New +$1.47M 0.02% 623

Other funds holding MDT

Integral Derivatives's MDT Position: Q4 2017 in Review

Integral Derivatives sold out of Medtronic (MDT) in Q4 2017, closing a stake of 6,616 shares — an estimated $530K sold.

Integral Derivatives first reported a position in MDT in Q3 2014 and held it in 8 quarters. The position peaked at $1.97M in Q4 2016. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Integral Derivatives reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 6,616 Medtronic shares in Q4 2017, an estimated $530K.
  • Integral Derivatives first reported a position in Medtronic in Q3 2014 and held it in 8 quarters.
  • Integral Derivatives's Medtronic position peaked at $1.97M in Q4 2016.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.